The expression of SIRT1 in nonalcoholic fatty liver disease induced by high-fat diet in rats

Liver International

Volumn 27, Issue 5, 2007, Pages 708-715

  Deng, Xiang Qun ^a   Chen, Lu Lu ^a   Li, Ning Xu ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Calorie restriction; High fat diet; Nonalcoholic fatty liver diseases; Rats; SIRT1

Indexed keywords

INSULIN; SIRTUIN; SIRTUIN 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALORIC RESTRICTION; CONTROLLED STUDY; HISTOPATHOLOGY; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID DIET; LIVER STRUCTURE; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PROTEIN EXPRESSION; RAT;

ANIMALS; CALORIC RESTRICTION; DIETARY FATS; FATTY LIVER; GENE EXPRESSION; INSULIN RESISTANCE; LIVER; MALE; RATS; RATS, WISTAR; SIRTUINS;

EID: 34547101692     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2007.01497.x     Document Type: Article

References (32)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-31.
2. Adams LA, Angulo P, Lindor KD. Nonalcoholic fatty liver disease. CMAJ 2005; 172: 899-905.
3. Day CP, James OF. Steatohepatitis: A tale of two "hits"? Gastroenterology 1998; 114: 842-5.
4. Chitturi S, Abeygunasekera S, Farrell GC, et al. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002; 35: 373-9.
5. Carmiel-Haggai M, Cederbaum AI, Nieto N. A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats. FASEB J 2005; 19: 136-8.
6. Guarente L, Picard F. Calorie Restriction - the SIR2 Connection. Cell 2005; 120: 473-82.
7. Cohen HY, Miller C, Bitterman KJ, et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 2004; 305: 390-2.
8. Fan JG, Tia LY, Ding XD, et al. Effects of low-calorie diet on steatohepatitis in rats with obesity and hyperlipidemia. World J Gastroenterol 2003; 9: 2045-9.
9. Lieber CS, Leo MA, Mak KM, et al. Model of nonalcoholic steatohepatitis. Am J Clin Nutr 2004; 79: 502-9.
10. Ugochukwu NH, Bagayoko ND, Antwi ME. The effects of dietary caloric restriction on antioxidant status and lipid peroxidation in mild and severe streptozotocin-induced diabetic rats. Clin Chim Acta 2004; 348: 121-9.
11. Festa A, Williams K, D'Agostino R Jr, et al. The natural course of beta-cell function in nondiabetic and diabetic individuals: The Insulin Resistance Atherosclerosis Study. Diabetes 2006; 55: 1114-20.
12. Li HL, Yu YR, Yu HL, et al. Relationship between peripheral insulin resistance and beta-cell function in obese subjects. Sichuan Da Xue Xue Bao Yi Xue Ban 2005; 36: 378-81.
13. Stefan N, Stumvoll M, Bogardus C, et al. Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT. Am J Physiol Endocrinol Metab 2003; 284: E1156-61.
14. Bordone L, Motta MC, Picard F, et al. Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic b cells. PLoS Biol 2006; 4: E31.
15. Zou Y, Li J, Lu C, et al. High-fat emulsion-induced rat model of nonalcoholic steatohepatitis. Life Sci 2006; 79: 1100-7.
16. Kraegen EW, Clark PW, Jenkins AB, et al. Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 1991; 40: 1397-403.
17. Astrup A, Meinert Larsen T, Harper A. Atkins and other low-carbohydrate diet: Hoax or an effective tool for weight loss? Lancet 2004; 364: 897-9.
18. Lara-Castro C, Garvey WT. Diet, insulin resistance, and obesity: Zoning in on data for Atkins dieters living in South Beach. J Clin Endocrinol Metab 2004; 89: 4197-205.
19. Adams LA, Angulo P. Treatment of non-alcoholic fatty liver disease. Postgrad Med J 2006; 82: 315-22.
20. Gill HK, Wu GY. Non-alcoholic fatty liver disease and the metabolic syndrome: Effects of weight loss and a review of popular diets. Are low carbohydrate diets the answer? World J Gastroenterol 2006; 12: 345-53.
21. Cettour-Rose P, Samec S, Russell AP, et al. Redistribution of glucose from skeletal muscle to adipose tissue during catch-up fat: A link between catch-up growth and later metabolic syndrome. Diabetes 2005; 54: 751-6.
22. Motta MC, Divecha N, Lemieux M, et al. Mammalian SIRT1 represses forkhead transcription factors. Cell 2004; 116: 551-63.
23. Brunet A, Sweeney LB, Sturgill JF, et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004; 303: 2011-5.
24. Vaziri H, Dessain SK, Ng Eaton E, et al. hSIR2 (SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 2001; 107: 149-59.
25. Luo J, Nikolaev AY, Imai S, et al. Negative control of p53 by Sir2 alpha promotes cell survival under stress. Cell 2001; 107: 137-48.
26. Langley E, Pearson M, Faretta M, et al. Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J 2002; 21: 2383-96.
27. Heilbronn LK, Civitarese AE, Bogacka I, et al. Glucose tolerance and skeletal muscle gene expression in response to alternate day fasting. Obes Res 2005; 13: 574-81.
28. Lopez-Lluch G, Hunt N, Jones B, et al. Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency. Proc Natl Acad Sci 2006; 103: 1768-73.
29. Rodgers JT, Lerin C, Haas W, et al. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005; 434: 113-8.
30. Pagans S, Pedal A, North BJ, et al. SIRT1 regulates HIV transcription via Tat deacetylation. PLoS Biol 2005; 3: E41.
31. Nemoto S, Fergusson MM, Finkel T. SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}. J Biol Chem 2005; 280: 16456-60.
32. Oliveira CP, Coelho AM, Barbeiro HV, et al. Liver mitochondrial dysfunction and oxidative stress in the pathogenesis of experimental nonalcoholic fatty liver disease. Braz J Med Biol Res 2006; 39: 189-94.